Viewing Study NCT07011056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-04-10 @ 8:54 PM
Study NCT ID: NCT07011056
Status: RECRUITING
Last Update Posted: 2025-09-19
First Post: 2025-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent and Refractory Diffuse Large B-cell Lymphoma View
Keywords: